CHRU de Lille-Hopital Claude Huriez Service des Maladies du Sang

Lille 59037

0 studies enrolling now · 3 studies all time

What they study most

Anemia, Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia (CMML), Low to Intermediate-1 MDS, Myelodysplastic Syndromes, Myelodysplastic Syndromes (MDS)

Studies at this site

• Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML) — Completed
• A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes — Completed
• A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q — Completed